Directa Plus Regulatory News (DCTA)

17 June 2022

Directa Plus plc

("Directa Plus" or the "Company")

Results of Annual General Meeting

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces the results of the voting on the resolutions put to its Annual General Meeting (the "Meeting") held earlier today. Each of the resolutions put to the Meeting were voted on by way of a poll. The results of the poll for each resolution will be available shortly on the Company's website at: http://www.directa-plus.com/

All the resolutions were successfully passed with the exception of resolutions 3 and 7 which were defeated. As a result, Sir Peter Middleton will step down as Chairman following the Meeting, which is in line with his intention to step down announced on the 19 May 2022. Richard Hickinbotham has been appointed interim Chairman. The Board of Directors is committed to an immediate process of consultation to review and refresh the constitution of the Board, in particular to bring additional diversity and expertise to the Company.

The Board notes that there was a significant minority who voted against all resolutions and the Board will engage with shareholders to understand their views. In accordance with the QCA Corporate Governance Code, to which the Company adheres, any action proposed by the Board following such engagement will be included in the Corporate Governance section of the Company's website.

Chief Executive Officer Giulio Cesareo commented: "I wish to thank Sir Peter for leading the Company since its flotation on AIM and providing me and the Board with the benefit of his long business experience and wisdom. Under his leadership the Company has developed a highly valued intellectual property portfolio with a large number of increasingly mature applications for our products and services.

"After many years of development, the graphene market has reached a point of inflection with high levels of growth now forecast. The Board believes that Directa is strongly positioned to take advantage of the opportunity and it is undertaking a detailed review of the strategy and associated resourcing to ensure the Company is able to do so. As part of this the Board is reviewing and seeking new capabilities to support the next phase of growth."

For further information please visit http://www.directa-plus.com/ or contact:

About Directa Plus

Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus' production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and paste.

This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products. Directa Plus' products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+®) have multiple applications due to its properties. These G+® products can be categorised into various families, with different products being suitable for specific practical applications.

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and has been listed on the AIM market of the London Stock Exchange since May 2016. The Company holds the Green Economy Mark from London Stock Exchange which recognises companies that contribute to the global green economy.

-ends-